Preface |
|
ix | |
Acknowledgments |
|
xi | |
Abbreviations and Symbols |
|
xiii | |
|
|
1 | (182) |
|
Overview of MRI and Basic Principles |
|
|
3 | (28) |
|
RF Excitation and Signal Generation |
|
|
31 | (11) |
|
Tissue Characteristics and Contrast Agents: PD, T1, and T2 |
|
|
42 | (9) |
|
|
51 | (30) |
|
Spatial Localization and Introduction to k-Space |
|
|
81 | (23) |
|
|
104 | (18) |
|
More k-Space: The Relationship between k-Space and the Image |
|
|
122 | (16) |
|
Fast Scanning and k-Space Shortcuts |
|
|
138 | (21) |
|
Selectively Saturating, Nulling, and Exciting Protons |
|
|
159 | (16) |
|
Safety and Cardiovascular MRI |
|
|
175 | (8) |
|
SECTION II: VASCULAR MR IMAGING |
|
|
183 | (72) |
|
|
185 | (12) |
|
Time-of-Flight MR Angiography |
|
|
197 | (7) |
|
Protocol: Carotid MRA without Gadolinium Contrast |
|
|
203 | (1) |
|
Pelvic MR Venography without Gadolinium Contrast |
|
|
203 | (1) |
|
Phase Contrast MRI: Flow Quantification and MRA |
|
|
204 | (13) |
|
Protocol: Aortic Coarctation |
|
|
216 | (1) |
|
Gadolinium-Enhanced MR Angiography |
|
|
217 | (38) |
|
Protocol: Carotid Artery MRA with Gadolinium Contrast |
|
|
246 | (1) |
|
Protocol: Thoracic Aorta MRA with Gadolinium Contrast |
|
|
247 | (1) |
|
Protocol: Abdominal Aorta/Renal Artery MRA with Gadolinium Contrast |
|
|
248 | (1) |
|
Protocol: Three-Station Peripheral MRA (Renal Arteries to Feet) with Gadolinium Contrast and Moving Table (Option A) |
|
|
249 | (1) |
|
Protocol: Four-Station Peripheral MRA (Renal Arteries to Feet) with Gadolinium Contrast and Manual Patient Move (Option B) |
|
|
250 | (2) |
|
Protocol: Three-Station Peripheral MRA (Renal Arteries to Feet) with Gadolinium Contrast with Separate Stations (Option C) |
|
|
252 | (2) |
|
Protocol: MR Venography of Chest with Gadolinium Contrast |
|
|
254 | (1) |
|
SECTION III: CARDIAC MR IMAGING |
|
|
255 | (106) |
|
|
257 | (9) |
|
|
266 | (8) |
|
|
274 | (9) |
|
Cine Gradient Echo Imaging |
|
|
283 | (24) |
|
Protocol: Left Ventricular Function |
|
|
306 | (1) |
|
Tissue Characterization in the Heart |
|
|
307 | (18) |
|
|
322 | (1) |
|
Protocol: Cardiac Viability |
|
|
323 | (1) |
|
Protocol: Arrhythmogenic Right Ventricular Dysplasia |
|
|
324 | (1) |
|
Phase Contrast Flow Quantification in the Heart |
|
|
325 | (12) |
|
Protocol: Aortic Valve Disease |
|
|
336 | (1) |
|
Protocol: Shunt Fraction Quantification |
|
|
336 | (1) |
|
|
337 | (13) |
|
Protocol: Ischemic heart Disease: Adenosine/Dipyridamole Perfusion Imaging |
|
|
348 | (1) |
|
Protocol: Ischemic Heart Disease: Dobutamine Contractility Imaging |
|
|
349 | (1) |
|
|
350 | (11) |
|
Protocol: Anomalous Coronary Arteries |
|
|
359 | (1) |
|
Protocol: Comprehensive Examination of Coronary Artery Disease |
|
|
360 | (1) |
Answers to Review Questions |
|
361 | (26) |
Glossary of Terms |
|
387 | (10) |
Index |
|
397 | |